Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma | Starlite/ChEMBL | References |
Homo sapiens | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha | Starlite/ChEMBL | References |
Homo sapiens | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta | Starlite/ChEMBL | References |
Homo sapiens | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma brucei | phosphatidylinositol 4-kinase alpha, putative | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta | 582 aa | 491 aa | 25.2 % |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha | 1068 aa | 927 aa | 29.0 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | hypothetical protein | 0.0415 | 0.5399 | 0.8126 |
Brugia malayi | LBP / BPI / CETP family, N-terminal domain containing protein | 0.038 | 0.4835 | 0.7276 |
Trichomonas vaginalis | phopsphatidylinositol 3-kinase, drosophila, putative | 0.0493 | 0.6644 | 1 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0415 | 0.5399 | 0.8126 |
Brugia malayi | LBP / BPI / CETP family, C-terminal domain containing protein | 0.0218 | 0.2221 | 0.3343 |
Leishmania major | phosphatidylinositol 4-kinase alpha, putative | 0.008 | 0 | 0.5 |
Echinococcus multilocularis | phosphatidylinositol 4,5 bisphosphate 3 kinase | 0.0701 | 1 | 1 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0493 | 0.6644 | 1 |
Brugia malayi | hypothetical protein | 0.0162 | 0.1323 | 0.1992 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0157 | 0.1245 | 0.1874 |
Echinococcus granulosus | tyrosine protein kinase Btk29A | 0.0583 | 0.8093 | 0.8093 |
Echinococcus multilocularis | phosphatidylinositol 4 phosphate 3 kinase C2 | 0.0276 | 0.3154 | 0.3154 |
Onchocerca volvulus | 0.038 | 0.4835 | 1 | |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0624 | 0.8755 | 1 |
Plasmodium falciparum | phosphatidylinositol 3-kinase | 0.008 | 0 | 0.5 |
Brugia malayi | LBP / BPI / CETP family, C-terminal domain containing protein | 0.0218 | 0.2221 | 0.3343 |
Loa Loa (eye worm) | hypothetical protein | 0.0162 | 0.1323 | 0.1512 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0139 | 0.0952 | 0.1087 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit alpha, beta, delta, putative | 0.0374 | 0.4735 | 0.7127 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0157 | 0.1245 | 1 |
Brugia malayi | hypothetical protein | 0.0218 | 0.2221 | 0.3343 |
Loa Loa (eye worm) | hypothetical protein | 0.0276 | 0.3154 | 0.3603 |
Echinococcus multilocularis | tyrosine protein kinase Btk29A | 0.0583 | 0.8093 | 0.8093 |
Onchocerca volvulus | 0.0218 | 0.2221 | 0.2556 | |
Onchocerca volvulus | 0.038 | 0.4835 | 1 | |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit gamma, putative | 0.0493 | 0.6644 | 1 |
Brugia malayi | LBP / BPI / CETP family, C-terminal domain containing protein | 0.038 | 0.4835 | 0.7276 |
Loa Loa (eye worm) | hypothetical protein | 0.0218 | 0.2221 | 0.2537 |
Onchocerca volvulus | 0.038 | 0.4835 | 1 | |
Leishmania major | phosphatidylinositol 3-kinase, putative | 0.008 | 0 | 0.5 |
Onchocerca volvulus | 0.0218 | 0.2221 | 0.2556 | |
Loa Loa (eye worm) | LBP/BPI/CETP family domain-containing protein | 0.0218 | 0.2221 | 0.2537 |
Brugia malayi | LBP/BPI | 0.0162 | 0.1323 | 0.1992 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase, putative | 0.0139 | 0.0952 | 0.1432 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0276 | 0.3154 | 0.4747 |
Brugia malayi | phosphoinositide 3'-hydroxykinase p110-alpha subunit, putative | 0.0208 | 0.2065 | 0.3109 |
Loa Loa (eye worm) | hypothetical protein | 0.0217 | 0.22 | 0.2512 |
Onchocerca volvulus | 0.038 | 0.4835 | 1 | |
Trypanosoma cruzi | phosphatidylinositol 3-kinase 2, putative | 0.0493 | 0.6644 | 1 |
Onchocerca volvulus | 0.038 | 0.4835 | 1 | |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0157 | 0.1245 | 0.1874 |
Schistosoma mansoni | phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K | 0.0157 | 0.1245 | 0.1245 |
Loa Loa (eye worm) | hypothetical protein | 0.0218 | 0.2221 | 0.2537 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0162 | 0.1323 | 0.1992 |
Trichomonas vaginalis | phosphatidylinositol kinase, putative | 0.0493 | 0.6644 | 1 |
Trichomonas vaginalis | phosphatidylinositol kinase, putative | 0.0157 | 0.1245 | 0.1874 |
Schistosoma mansoni | tyrosine kinase | 0.0572 | 0.7927 | 0.7927 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.0199 | 0.1909 | 0.2873 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase catalytic subunit alpha, beta, delta, putative | 0.0157 | 0.1245 | 0.1874 |
Loa Loa (eye worm) | LBP/BPI/CETP family domain-containing protein | 0.0218 | 0.2221 | 0.2537 |
Onchocerca volvulus | 0.038 | 0.4835 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0218 | 0.2221 | 0.2537 |
Loa Loa (eye worm) | hypothetical protein | 0.038 | 0.4835 | 0.5522 |
Brugia malayi | LBP / BPI / CETP family, N-terminal domain containing protein | 0.038 | 0.4835 | 0.7276 |
Loa Loa (eye worm) | hypothetical protein | 0.0162 | 0.1323 | 0.1512 |
Loa Loa (eye worm) | hypothetical protein | 0.0218 | 0.2221 | 0.2537 |
Schistosoma mansoni | phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K | 0.0701 | 1 | 1 |
Brugia malayi | LBP / BPI / CETP family, C-terminal domain containing protein | 0.0218 | 0.2221 | 0.3343 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase 2, putative | 0.0493 | 0.6644 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0157 | 0.1245 | 0.1874 |
Loa Loa (eye worm) | LBP/BPI/CETP family domain-containing protein | 0.038 | 0.4835 | 0.5522 |
Onchocerca volvulus | 0.038 | 0.4835 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0218 | 0.2221 | 0.2537 |
Trypanosoma cruzi | phosphatidylinositol 3-kinase vps34-like | 0.0157 | 0.1245 | 0.1874 |
Toxoplasma gondii | phosphatidylinositol 3- and 4-kinase | 0.008 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0162 | 0.1323 | 0.1512 |
Brugia malayi | hypothetical protein | 0.0218 | 0.2221 | 0.3343 |
Plasmodium vivax | phosphatidylinositol 3-kinase, putative | 0.008 | 0 | 0.5 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase class, putative | 0.0374 | 0.4735 | 0.7127 |
Loa Loa (eye worm) | hypothetical protein | 0.0162 | 0.1323 | 0.1512 |
Echinococcus granulosus | phosphatidylinositol 4 phosphate 3 kinase C2 | 0.0276 | 0.3154 | 0.3154 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0493 | 0.6644 | 1 |
Onchocerca volvulus | 0.038 | 0.4835 | 1 | |
Entamoeba histolytica | phosphatidylinositol 3-kinase 1, putative | 0.0474 | 0.6351 | 0.9559 |
Giardia lamblia | Phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0.0297 | 0.349 | 1 |
Toxoplasma gondii | phosphatidylinositol 3- and 4-kinase | 0.008 | 0 | 0.5 |
Trichomonas vaginalis | phosphatidylinositol 3-kinase class, putative | 0.0157 | 0.1245 | 0.1874 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 75 nM | Inhibition of PI3Kbeta in human PTEN-deficient PC3 cells assessed as Akt phosphorylation at S473 | ChEMBL. | 24560540 |
IC50 (binding) | = 130 nM | Inhibition of human PI3Kbeta after 15 mins | ChEMBL. | 24560540 |
IC50 (binding) | = 567 nM | Inhibition of human PI3Kdelta after 15 mins | ChEMBL. | 24560540 |
IC50 (binding) | = 4203 nM | Inhibition of human PI3Kgamma after 15 mins | ChEMBL. | 24560540 |
IC50 (binding) | > 10000 nM | Inhibition of human PI3Kalpha after 15 mins | ChEMBL. | 24560540 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.